Article info
PDFPostScript
Letter
Comparison of the long-term efficacy between tenofovir and entecavir in chronic hepatitis B patients
- Correspondence to Professor Jiean Huang, Department of Gastroenterology, Guangxi Medical University, Nanning 530000, China; hjaxiaohua{at}126.com
Citation
Comparison of the long-term efficacy between tenofovir and entecavir in chronic hepatitis B patients
Publication history
- Received July 27, 2020
- Revised August 25, 2020
- Accepted August 31, 2020
- First published September 14, 2020.
Online issue publication
January 23, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.